The ELF is currently involved in two EU projects, U-BIOPRED and AirPROM.
These projects aim to raise awareness of lung diseases and inform people about the latest respiratory research.
Each project has a website created by the ELF website, to explain more about the projects aims and objectives, what they hope to achieve and how to get involved.
The projects have their own individual aims but share a common theme: to improve understanding of lung diseases and help advance new therapies.
All websites are updated and maintained by the ELF.
U-BIOPRED: 
(Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) aims to understand more about severe asthma and involves scientists from universities, research institutes, the pharmaceutical industry and small companies.
AirPROM: aims to develop a tool to be used in clinical trials, to improve the management of severe asthma and COPD by considering all symptoms. The tool will be used to determine the most suitable treatment and predict treatment responses.
Other involvement in EU projects
PROactive: aims to develop, validate and use patient reported outcome (PRO) tools to investigate levels of physical activity in people with chronic obstructive pulmonary disease (COPD).
Patient factsheet: Living an active life with COPD.
TB PAN-NET: aims to establish a consortium of expert partners to address the challenge of drug-resistant TB facing the EU.
Patient factsheets: Tuberculosis (TB) and Multi-drug resistant tuberculosis (MDR-TB).
GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe): working to combat antibiotic resistance in community-acquired lower respiratory tract infections.
Patient factsheets: Acute bronchitis and Asthma and infection.
Other EU projects of interest
MedALL (Mechanisms of the Development of ALLergy): aims to improve the health of European citizens by investigating the causes of allergy.